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Abstract
Background: Against a background of interest in rates of diabetes in schizophrenia and related
psychoses and claims that data from historical periods demonstrate a link that antedates modern
antipsychotics, we sought to establish the rate of diabetes in first onset psychosis and subsequent
prevalence in historical and contemporary cohorts.
Methods: Analysis of two epidemiologically complete databases of individuals admitted for mental
illness. 3170 individuals admitted to the North Wales Asylum between 1875–1924 and tracked
over 18,486 patient years and 394 North West Wales first admissions for schizophrenia and
related psychoses between 1994 and 2006 and tracked after treatment.
Results: The prevalence of Type 2 diabetes among patients with psychoses at time of first
admission in both historical and contemporary samples was 0%. The incidence of diabetes remained
0% in the historical sample throughout 15 years of follow-up but rose in the contemporary sample
after 3, 5 and 6 years of treatment with an incidence rate double the expected population rate so
that the 15 year prevalence is likely to be over 8%.
Conclusion: No association was found between diabetes and serious mental illness, but there may
be an association between diabetes and treatment.
Background
A series of recent studies have uniformly shown a preva-
lence of diabetes in patients with schizophrenia 2 to 4
times greater than is found in the rest of the population
[1-4]. Interest in a link between diabetes and serious men-
tal illness has arisen against a background of concerns that
antipsychotic agents might trigger diabetes. A competing
hypothesis is that this increase in prevalence might arise if
mental illnesses like schizophrenia predispose to diabe-
tes. The evidence in favour of this latter hypothesis
depends heavily on claims that the recognition of such a
link antedates the use of antipsychotic drugs [3].
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tion have diabetes [5,6]. If estimates that patients with
serious mental illness are 2 to 4 times more likely to have
diabetes than the rest of the population apply to an
untreated population, while taking into account that dia-
betes has hugely increased in prevalence, we might expect
a substantial number of those admitted to an asylum in
the pre-antipsychotic era to have had manifestations of
diabetes. We might also expect to find cases of diabetes
among untreated first admissions for serious mental ill-
ness today. In North West Wales, we have historical and
contemporary databases for serious mental illnesses that
allow us to shed some light on these issues.
Methods
There are a number of features of the datasets outlined
below that offer opportunities to study the incidence of
hospitalisation for and prevalence of hospitalised mental
disorders and concomitant physical disorders. First, the
population of North West Wales has remained essentially
the same between the 1875–1924 period and now [7].
Second, geographical and financial constraints mean
there has been nowhere else for patients with serious
mental illness to access a service other than through the
North Wales Asylum in the first instance and the services
of the North West Wales Trust latterly. Third information
systems in place enable us to track all patients and their
care whether they remain in area or not. Fourth the popu-
lation accessing services was and remains ethnically
homogenous, with over 80% during the 1875–1924
period and over 66% in the contemporary sample having
traditional Welsh surnames. For the purpose of this study
we have looked at all admissions for schizophrenia, other
non-affective psychoses, bipolar disorder, and manic epi-
sodes, as these are the patients who are now thought at
risk of diabetes, and the patients most likely to be treated
with antipsychotic agents.
North West Wales historical database
The first dataset consists of admissions from North West
Wales to the North Wales Asylum between 1875 and
1924. All diagnoses were made according to ICD-10 crite-
ria before this study was undertaken [7]. The historical
records offered four sets of information relevant to diag-
nosis of both mental illness and diabetes. First, all
patients were compulsorily detained and their records
included the medical and legal certificates outlining the
circumstances that led to detention. Second, the records
contain standard demographic data including age, sex,
educational, employment and marital status, family his-
tory of illness and the individual's prior mental or physi-
cal illness. Third, there was a description of the patients'
mental and physical state on admission, including refer-
ence to pre-existing disorders like diabetes, and prior
mental illness. Fourth, there was a set of case notes cover-
ing the patient's stay in hospital until discharge or death,
which in addition gave details of emerging physical ill-
nesses and causes of death in patients who died in hospi-
tal. We could retrieve the records of prior admissions back
to 1865 or subsequent admissions through to 1965. Cli-
nicians making a diagnosis did so on the basis of a full set
of records from all admissions for that patient rather than
simply on the case record for that admission. We were also
able to track the clinical course of patients for 50 years or
more.
Based on this information, diagnoses for schizophrenia
(F20), schizoaffective disorders (F25), delusional disor-
ders (F22), acute and transient psychotic disorders (F23),
and bipolar disorder (F31) were clear cut. A further group
of patients were diagnosed as unspecified non-organic
psychoses (F29), if the clinical details were insufficient to
sustain a definitive diagnosis, or manic episode (F30) if
the clinical course did not produce further episodes.
The presence of diabetes was readily determined from the
notes, which distinguish clearly between diabetes mellitus
and diabetes insipidus. Patients were noted to have diabe-
tes mellitus on admission, or to have developed it while
in care, or to have had the diagnosis recorded on their
death certificates. Diabetes in this cohort connotes a med-
ical diagnosis rather than a determination of diabetic sta-
tus on the basis of glycaemic status or glucose tolerance
test abnormalities. Once diagnosed, the condition could
clearly be managed medically, with several patients sur-
viving for over a year after first diagnosis.
We have established the incidence and prevalence of dia-
betes over 3, 5, 6 and 15 years from admission to compare
the historical and contemporary cohorts. But we have also
used the period of observation for the emergence of dia-
betes in the historical cohort, covering 13,117 hospital
years and 18,486 patient years, to establish prevalence
over the full treatment period.
Contemporary first admissions for psychosis
The second dataset is drawn from an ongoing study of
service utilisation for non-affective and affective psycho-
ses from North West Wales. Patients were included in this
study if they were native to or resident in North Wales fol-
lowing an initial hospitalisation for affective or non-affec-
tive psychosis. We have not included patients not resident
in or native to North Wales, who had an initial illness epi-
sode in North Wales but left the region thereafter, such as
college students.
From records of all patients admitted to the only District
General Hospital Unit in the North West Wales, we have
assembled all patients with first admissions between 1994
and 2006 for conditions with an F20 – F29 diagnosis orPage 2 of 8
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episode (F30). Initial cross-sectional diagnoses made by
sector consultant psychiatrists were supplemented by lon-
gitudinal data with renewed consultant and community
mental health team diagnostic input.
The incidence of diabetes at first admission, and the emer-
gence of cases within 3, 5 and 6 years of first admission,
was determined by scrutinising the case notes in the first
instance. Second we accessed the North West Wales hos-
pital database for all patients listed in our cohort for evi-
dence of diabetes not recorded in their mental health
records. Third, the electronic records of all patients receiv-
ing hospital care for diabetes were scrutinised to access
those with a coincident mental health diagnosis for possi-
ble cases of psychoses missed from the hospitalised
cohort. Fourth we accessed pharmacy records for all
patients receiving treatments for diabetes while in psychi-
atric inpatient care. Fifth we contacted the primary care
physicians looking after all living patients in the cohort to
establish whether any patients might be receiving treat-
ment for diabetes who had not accessed the hospital med-
ical services for diabetes treatment. A diagnosis of
diabetes, in this sample, as in the historical cohort, con-
notes a medical diagnosis and the institution of manage-
ment strategies, rather than a diagnosis based on inference
from glycaemic or glucose tolerance abnormalities.
Ethical approval
This study was approved by the North West Wales Ethics
committee. Written informed consent was sought from
patients in the contemporary sample not currently in con-
tact with the mental health services to interrogate their
medical histories.
Results
1875–1924 cohort
In the period from 1875 to 1924, there were 3872 admis-
sions from 3170 individuals to the asylum from North
West Wales. In 39 cases incomplete records made psychi-
atric diagnosis impossible. Of the remaining 3833 admis-
sions, there were 1,303 admissions from 1,040
individuals diagnosed with a psychotic disorder, of which
741 admissions were diagnosed with schizophrenia or
schizoaffective disorder from a total of 593 individuals. A
further 185 admissions from 153 individuals were diag-
nosed as delusional disorders, and 377 episodes from 294
individuals were diagnosed as acute and transient psy-
chotic disorders or other non-organic psychoses. In addi-
tion there were 356 admissions from 135 individuals
admitted for bipolar disorder and 74 admissions from 73
patients with manic episodes. There were therefore 1733
admissions from 1248 individuals in total. The compara-
tive ages at first admission broken down by diagnosis of
the historical and contemporary cohorts are laid out in
Tables 1 &2.
At the time of admission, none of the 1248 patients with
schizophrenia or other non-affective psychosis had diabe-
tes. Two of the remaining 1972 individuals had diabetes
on admission, one of whom was a 63-year-old man with
chronic alcoholism. The second was a 48-year-old lady,
who was recorded as having developed diabetes 12
months previously, who died 9 days after admission to
Table 1: 1875–1924 Admissions by Age, Gender & Diagnosis
Diagnosis 10–24 25–34 35–44 45–54 55–64 65+ Total
Schizophrenia
Male 79 113 64 26 8 5 295
Female 54 99 82 47 13 3 298
Delusional Disorder
Male - 6 15 22 10 10 63
Female - 3 17 43 18 9 90
Acute & Transient Psychoses F23
Male 20 12 18 10 3 7 70
Female 8 11 19 17 10 3 68
Unspecified Psychoses F29
Male 19 19 16 11 12 3 80
Female 9 21 15 16 9 6 76
Bipolar Disorder
Male 8 12 9 9 7 2 47
Female 12 26 22 17 5 6 88
Manic Episode
Male 9 8 7 2 4 4 34
Female 17 9 9 4 - - 39
TOTAL 135 170 129 80 44 31 589Page 3 of 8
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sion behaviour and clinical course point to an organic dis-
order rather than a psychotic disorder, as defined above.
A further 3 patients developed diabetes in hospital. Of
these 2 patients came from the non-psychotic group – one
had a learning disability and epilepsy and appears to have
developed diabetes after 30 years in hospital. A second
was a lady who was 58 years old on admission for severe
recurrent psychotic depression who developed diabetes
after 6 years in hospital.
The third patient was a lady who was 43 years old on
admission with manic-depressive illness who developed
diabetes after 30 years in hospital. This case gives a preva-
lence for the historical cohort of 1 case of diabetes in 1248
patients, followed closely for over 18,000 patient years.
No case in the historical sample developed diabetes
within 3, 5, 6 or 15 years of hospitalisation.
These 5 cases, two at admission, and three who developed
diabetes subsequently, were admitted at regular intervals
through the sample, from 1883 to 1923.
Diabetes prevalence is commonly cited separately for the
18–44 year old and for 45 years and older groups. Of the
1248 individuals with serious mental illness, 812 were in
the 18–44 year age bracket at time of admission. At popu-
lation prevalence rates for diabetes for the 1950s [5]
assuming mental illness does not dispose to diabetes, we
would have expected 3 cases from the 18–44 year age
bracket and up to a further 8 from the older patients, 11
in total.
While the 1875–1924 prevalence of diabetes in the wider
population was almost certainly lower than the preva-
lence estimates from the 1950s [4], it can be noted that a
significant number of our sample lived through to the
1950s and the only case who developed diabetes from the
target group was diagnosed in the 1950s.
1994–2006 cohort
There were 394 first admissions for schizophrenic, other
non-affective psychoses, manic or bipolar disorders to the
North West Wales mental health services in this period. Of
these 186 had schizophrenia, 42 had delusional disor-
ders, 44 had acute and transient psychoses, 77 had
unspecified psychoses, and 45 had bipolar disorder or a
manic episode.
One patient with an acute and transient psychosis had
pre-existing Type 1 diabetes at the time of admission. No
patients with schizophrenia or other non-affective psy-
choses, bipolar disorder or manic episode had Type 2 dia-
betes at the time of first admission (Table 3).
Six patients developed Type 2 diabetes, 5 males and 1
female, following their first admission. Of these 6, 4 have
schizophrenia, one a psychosis linked to prior alcohol
abuse (F29), and one bipolar disorder. Two of the 6 devel-
Table 2: 1994–2006 Admissions by Age, Gender & Diagnosis
Diagnosis 10–24 25–34 35–44 45–54 55–64 65+ Total
Schizophrenia
Male 65 41 15 3 - - 124
Female 19 18 20 3 2 - 62
Delusional Disorder
Male 1 4 5 2 6 4 22
Female - 1 - 6 2 11 20
Acute & Transient Psychoses F23
Male 7 8 4 1 2 1 23
Female 5 5 6 2 1 2 21
Unspecified Psychoses F29
Male 21 19 3 2 1 1 47
Female 4 6 8 3 1 8 30
Bipolar Disorder
Male 6 3 6 2 2 1 20
Female 3 9 7 2 1 3 25
Manic Episode*
Male - - - - - - -
Female - - - - - - -
TOTAL 100 75 33 10 11 7 236
31 39 41 16 7 24 158
*Manic episode patients included with Bipolar DisorderPage 4 of 8
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serious mental illness, both under the age of 45. Two
more developed diabetes within 5 years, one under 45
and one over 45. A further two developed diabetes shortly
after 5 years of follow-up, one under 45 and one over 45.
All 4 patients under the age of 45 were on ongoing treat-
ment with atypical antipsychotics.
Within this contemporary sample, 319 were under the age
of 45 at point of first admission. Population norms for the
contemporary prevalence of diabetes suggest we might
have expected 3 patients with diabetes in this cohort.5
There were a further 75 patients over the age of 45 at time
of first presentation, from whom 4.5 cases of diabetes
might have been expected. The expected number of diabe-
tes cases therefore was 7, whereas the observed prevalence
on first admission was 1 case. The expected number of
cases after 6 years of follow up in those under 45 was 3,
whereas the observed number was 5 cases.
As of the time of writing, 1.5% of the original contempo-
rary cohort has Type 2 diabetes. However, 36 of the cohort
have died and not all the cohort has 3, 5 or 6-year follow
up data. Basing prevalence estimates on the proportion of
living cases with completed data in each of these follow-
up periods, the prevalence of diabetes at 3 years was 0.7%,
at 5 years was 1.8% and at 6 years was 3.1%. This 6-year
figure gives an incidence rate of 5.1 cases/1,000 patient
years. At 15 years the prevalence rate is likely to be over
8%.
When patients with acute and transient psychoses, and
manic episodes, as well as bipolar disorders are removed,
the prevalence of diabetes in non-affective psychoses (pri-
marily schizophrenia) is 0.9% at 3 years, 2.4% at 5 years,
and 3.3% at 6 years. This latter figure gives an incidence
rate of 5.4 cases/1,000 patient years.
Comparing the historical and contemporary cohorts, the
relative risk of presenting at first admission with Type 2
diabetes for both cohorts was similar. While any compar-
isons between the relative risk of developing diabetes for
the contemporary and historical cohorts are necessarily
compromised by the different prevalence of the disorder
during the two periods, our data at present point to a 0%
15 year prevalence in the historical cohort compared with
a likely 8% prevalence in the contemporary cohort. Based
on actual cases at any time point, the data points to a 21.9
times (95% C.I 2.7, 177.8) greater risk for the contempo-
rary cohort.
Including cases from the index cohort, our interrogation
of general hospital, pharmacy, and general practice
records netted 71 patients with diabetes and a non-affec-
tive disorder psychosis or bipolar disorder that have had
hospital contact. There were 1031 individuals listed in the
electronic database of the North West Wales Trust as hav-
ing received medical care between 1996 and 2006 who
had a diagnosis of both diabetes and a mental illness. Of
these 1031 individuals, 368 had a dementing or other
organic disorder (F00–09), of whom a large number died
within months of diagnosis, 204 had an alcohol or other
substance abuse related disorder (F10–19), 45 had a non-
affective psychotic disorder (F20–29), 230 had an affec-
tive disorder (F30–39) and 284 had an anxiety based or
personality linked problem (F40–69).
Discussion
The figure reported here for 6-year prevalence for Type 2
diabetes in the contemporary cohort is over 3%. This is
not inconsistent with the 13% figure for prevalence of dia-
betes in a sample of living patients after an average of over
14 years of treatment for schizophrenia stemming from
the recent CATIE study [2]. Our findings show an inci-
dence rate of diabetes in the contemporary sample of
schizophrenic patients of 5.4/1000 patients per year,
which is double the figures for the incidence of diabetes
Table 3: Prevalence of Type 2 Diabetes in 1875–1924 & 1994–2006 Cohorts
Diagnosis Prevalence of Diabetes 
at Admission: 
1875–1924
Six Year Prevalence of 
Diabetes: 1875–1924
Prevalence of Diabetes 
at Admission: 
1994–2006
Six Year Prevalence of 
Diabetes: 1994–2006
Schizophrenia 0% 0% 0% 3.3%
Delusional Disorder 0% 0% 0% 0%
Acute & Transient 
Psychoses F23
0% 0% 0% 0%
Unspecified Psychoses 
F29
0% 0% 0% 2.2%
Bipolar Disorder 0% 0% 0% 2.7%
Manic Episode 0% 0% 0% 0%
TOTAL 0% 0% 0% 3.1%Page 5 of 8
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[5]. This puts us on track for a 15-year prevalence rate of
8%; the final figure may be greater as diabetes incidence
rates increase with age [4].
This incidence rate is lower than incidence rates of 1.3%
and 4.4% reported for other groups of psychotic patients
[8,9]. These other samples however have not been drawn
from patients newly admitted for psychosis and the mean
age of the samples and mean duration of treatment have
almost certainly been greater than the mean age and dura-
tion of treatment found in this sample.
As a control on our findings, we report data from the com-
bined medical and psychiatric services for the prevalence
of diabetes in subjects with any mental illness. These are
consistent with findings for diabetes in general – it is most
common in the elderly (dementia) and in women and in
those with substance misuse problems – suggesting that
our "assay" system has been performing acceptably.
There are, nevertheless, a number of limitations to this
study. In the first place it is a study of service contacts only
rather than a complete survey of all incident cases of either
psychosis or diabetes in the wider population. Second, a
number of health service populations are put on antipsy-
chotics, including cases of dementia, alcohol abuse and
personality linked problems, but we have not sought to
establish the prevalence for diabetes among all patients
before and after treatment with antipsychotic drugs. Third
we have not sought to determine the prevalence of diabe-
tes among previously hospitalised chronic psychotic
patients, as many of these are managed exclusively in pri-
mary care, thus creating problems in ensuring we have a
complete sample. Fourth, our definition of diabetes is a
clinical one: we have not sought to determine on the basis
of blood glucose values all possible cases of diabetes. Fifth
owing to changing population prevalence for diabetes, the
historical and contemporary cohorts cannot be directly
compared.
However, the study is epidemiologically complete, in that
we can be reasonably certain there is no one from this
catchment population of 240,000 during either the his-
torical or contemporary periods who had a first episode of
psychosis and who accessed services of whom we are una-
ware. Second of those receiving a service, we can be rea-
sonably confident that we have detected in both cohorts
all cases receiving a clinical diagnosis of diabetes. Third,
the study sheds light on the incidence rate for diabetes in
a first admitted population. Fourth, this study uniquely
sheds light on an epidemiologically complete population
from the pre-antipsychotic era.
The findings are inconsistent with widely cited sugges-
tions of a link between diabetes and serious mental ill-
ness. The present study suggests strongly that patients
with serious mental illness are not predisposed to diabe-
tes. These findings are consistent with recent studies that
find no evidence of diabetes at the point of first admission
for schizophrenia [10,11]. Indeed the findings are not
inconsistent with the possibility that untreated serious
mental illness has a protective effect against diabetes.
Current perceptions of a link between serious mental ill-
ness and diabetes stem in part from a series of articles
from the pre-antipsychotic. A great deal hinges on claims
that Henry Maudsley had anecdotally noted a connection
between mental illness and diabetes in the late 19th cen-
tury. Aside from this claim there is in fact no other refer-
ence to patients having diabetes.
A series of articles have reported hyperglycemia or abnor-
mal glucose tolerance tests in patients with serious mental
illness [12-17]. It is not clear however that these findings
should be taken as indicators of unrecognised diabetes.
Much of this early work was undertaken on catatonic
patients, who it is well known demonstrate autonomic
instability leading to fluctuations of blood pressure, tem-
perature and heart rate, which normalise on recovery. Just
as one would not take blood pressure elevations in cata-
tonic states as evidence of latent hypertension, it may also
be a mistake to interpret fluctuating glucose levels or
abnormal glucose tolerance tests in untreated mental ill-
ness as indicative of a pre-diabetic state. The authors in
these papers do not describe any of their patients as dia-
betic.
In contrast to the relative lack of data supporting a link
between diabetes and serious mental illness, from as early
as the mid-1950s, a series of articles have outlined eleva-
tions in glucose levels or aggravation of pre-existing diabe-
tes following treatment with the earliest antipsychotics
[18-23].
While Type 1 diabetes with an onset in childhood was
inconsistent with survival before 1924 and therefore such
cases could not have presented to the asylum, Type 1 cases
remain rare today, and recent population studies suggest
there is no correlation between Type 1 diabetes and psy-
chosis [12].
Type 2 diabetes is the only kind that could have led to sug-
gestions of a link between the two illnesses and, today,
Type 2 accounts for 85% of cases of diabetes. Type 2 dia-
betes was readily recognised in the historical period and
managed by dietary measures, with patients often surviv-
ing for years. The data from the historical period in this
study contrast with the regularly cited anecdotal observa-Page 6 of 8
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to patients, about a link between mental illness and dia-
betes. Indeed one value of this study is that it indicates
how unreliable the observations of a single clinician are
likely to have been, particularly during an era when diabe-
tes was less prevalent than now.
While factors such as lifestyle and diet unquestionably
play a part in producing the differences between contem-
porary and historical cohorts, in this case the contempo-
rary cohort can act as their own control for such factors,
and it seems unlikely that changes in lifestyle alone would
produce a doubling of the expected incidence of diabetes
in patients in such a short period of time, without the
operation of a further contributing factor, such as drug
treatment. A further pointer to the role of drug treatment
lies in the distribution of incipient cases of diabetes which
were more likely to arise in the schizophrenia than from
other groups in the contemporary cohort. While compli-
ance with ongoing therapy cannot be assumed in this
group, it nevertheless seems more likely in this group than
in the patients with acute and transient disorders for
instance, who are encouraged to discontinue treatment on
recovery.
Conclusion
The absence of cases of Type 2 diabetes before the onset of
psychosis, in either the contemporary or historical mental
illness samples, combined with a more rapid rate of devel-
opment of Type 2 diabetes in the contemporary sample
than is the norm in the population in general, appears to
make it more likely that treatment with antipsychotic
drugs rather than the underlying illness contributes to the
current prevalence rates found for diabetes in patients
with serious mental illness.
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